Cancer immunotherapy: predict outcomes better with combination biomarkers, Zurich, Donnerstag, 10. Oktober 2019

Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes.
I also show an easy way to combine them and improve their predictions, using a combination biomarker. Finally, I make suggestions of practical ways to contribute to research on this topic.
Speaker: Mostapha Benhenda, bioinformatician at Melwy.com
You will receive the link to the lectures by registering to this event.

Cancer immunotherapy: predict outcomes better with combination biomarkers

Weitere interessante Veranstaltungen
Holen Event Empfehlungen basierend auf Ihre Facebook-Geschmack. Hol es dir jetzt!Zeigen Sie mir die passenden Veranstaltungen für michNicht jetzt